Skip to main content
. 2020 Jun 20;4(2):783–798. doi: 10.1093/tas/txaa083

Table 1.

Description of dietary treatments in terms of Zn and Cu sources and levels and phytase inclusion levels

Trt Zn sources Zn levels in phase 1, 2, and 3 diets, mg/kg Cu sources Cu levels in phase 1, 2, and 3 diets, mg/kg Phytasec, FTU/kg
1 ZnO 2,000, 2,000, 100 CuSO4 150, 80, 80 0
2 ZnO 2,000, 2,000, 100 Cu-MHACb 150, 80, 80 0
3 Zn-MHACa 100, 100, 100 CuSO4 150, 80, 80 0
4 Zn-MHAC 100, 100, 100 Cu-MHAC 150, 80, 80 0
5 ZnO 2,000, 2,000, 100 CuSO4 150, 80, 80 500
6 ZnO 2,000, 2,000, 100 Cu-MHAC 150, 80, 80 500
7 Zn-MHAC 100, 100, 100 CuSO4 150, 80, 80 500
8 Zn-MHAC 100, 100, 100 Cu-MHAC 150, 80, 80 500

aZn-MHAC represents Zn methionine hydroxy analogue chelate (MINTREX Zn), which is manufactured by Novus International Inc., St. Charles, MO.

bCu-MHAC represents Cu methionine hydroxy analogue chelate (MINTREX Cu), which is manufactured by Novus International Inc., St. Charles, MO.

cPhytase used in this study is a commercial feed-grade phytase (Quantum Blue, AB Vista, Marlborough, UK), with analyzed activity of 6,033 FTU/g.